Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1348)	8/1/2005 3:18:45 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

GORX Traded above its July 26 H of 3.00 at 1.51PM as it reached its intraday H of 1.20 The nearest support is now at 2.88 and resistance at 3.05 GORX has a D/E around 0.23 The revenues on the 1stQ were up 22% to 8.4M but the loss remained unchanged at $0.02/shr. The stock is up a modest 22% today, but still significantly below its December 1 H of 11.25 (That was the day of its good upgap on volume of 42,535,360 <g> December 1 was the day when the trading was halted after some confusion at the FDA.<g> The FDA first sayed that Mucotrol wasn't approved, then backtracked and sayed it had received marketing clearance.<g> The confusion was apparently caused because the FDA officials were checking in the agency's drug division and not its medical device division, according to GORX's President><g> bigcharts.marketwatch.com Bernard